FOXO TECHNOLOGIES INC. Selling, General and Administrative Expense
FOXO TECHNOLOGIES INC. (FOXO) reported Selling, General and Administrative Expense of $2.68 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $2.68M, a 2.31% increase year-over-year.
- FOXO TECHNOLOGIES INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $2.88M, a 4.02% increase year-over-year.
- FOXO TECHNOLOGIES INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $3.50M, a 15.63% increase year-over-year.
- FOXO TECHNOLOGIES INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $2.47M, a 42.76% increase year-over-year.
- FOXO TECHNOLOGIES INC. selling, general and administrative expense for fiscal 2025 was $11.36M, a 57.21% increase from fiscal 2024.
- FOXO TECHNOLOGIES INC. selling, general and administrative expense for fiscal 2024 was $7.23M, a 62.76% decline from fiscal 2023.
- FOXO TECHNOLOGIES INC. selling, general and administrative expense for fiscal 2023 was $19.40M, a 24.88% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. selling, general and administrative expense for fiscal 2022 was $25.83M, a 151.42% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.68M 10-Q · filed 2026-08-14 | $5.55M 10-Q · filed 2026-08-14 | $9.06M derived: sum of 3 quarters · filed 2026-08-14 | $11.53M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $2.88M 10-Q · filed 2026-05-15 | $6.38M derived: sum of 2 quarters · filed 2026-05-15 | $8.85M derived: sum of 3 quarters · filed 2026-05-15 | $11.47M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $5.98M derived: sum of 2 quarters · filed 2026-04-15 | $8.59M derived: sum of 3 quarters · filed 2026-08-14 | $11.36M 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $2.47M 10-Q · filed 2025-11-10 | $5.09M derived: sum of 2 quarters · filed 2026-08-14 | $7.86M 10-Q · filed 2025-11-10 | $10.89M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $2.62M 10-Q · filed 2026-08-14 | $5.38M 10-Q · filed 2026-08-14 | $8.41M derived: sum of 3 quarters · filed 2026-08-14 | $10.14M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $2.76M 10-Q · filed 2026-05-15 | $5.79M derived: sum of 2 quarters · filed 2026-05-15 | $7.53M derived: sum of 3 quarters · filed 2026-05-15 | $9.00M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $4.76M derived: sum of 2 quarters · filed 2026-04-15 | $6.24M derived: sum of 3 quarters · filed 2026-04-15 | $7.23M 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | $1.73M 10-Q · filed 2025-11-10 | $1.73M 10-Q · filed 2024-11-19 | $3.21M derived: sum of 2 quarters · filed 2025-11-10 | $4.20M 10-Q · filed 2025-11-10 | $4.20M 10-Q · filed 2024-11-19 | $8.54M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $1.47M 10-Q · filed 2025-08-19 | $1.47M 10-Q · filed 2024-08-19 | $2.46M 10-Q · filed 2025-08-19 | $2.46M 10-Q · filed 2024-08-19 | $6.81M derived: sum of 3 quarters · filed 2025-08-19 | $11.53M derived: sum of 4 quarters · filed 2025-08-19 | ||
| 2024-03-31 | $987.94K 10-Q/A · filed 2025-08-19 | $988.00K 10-Q · filed 2024-06-28 | $5.34M derived: sum of 2 quarters · filed 2025-08-19 | $10.05M derived: sum of 3 quarters · filed 2025-08-19 | $14.06M derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2023-12-31 | $4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $9.06M derived: sum of 2 quarters · filed 2025-04-15 | $13.07M derived: sum of 3 quarters · filed 2025-04-15 | $19.40M 10-K · filed 2025-04-15 | $19.40M 10-K · filed 2024-06-06 | |||
| 2023-09-30 | $4.72M 10-Q · filed 2024-11-19 | $8.72M derived: sum of 2 quarters · filed 2024-11-19 | $15.05M 10-Q · filed 2024-11-19 | $23.64M derived: sum of 4 quarters · filed 2024-11-19 | ||||
| 2023-06-30 | $4.00M 10-Q · filed 2024-08-19 | $10.34M 10-Q · filed 2024-08-19 | $18.92M derived: sum of 3 quarters · filed 2024-08-19 | $27.19M derived: sum of 4 quarters · filed 2024-08-19 | ||||
| 2023-03-31 | $6.33M 10-Q · filed 2024-06-28 | $14.92M derived: sum of 2 quarters · filed 2024-06-28 | $23.19M derived: sum of 3 quarters · filed 2024-06-28 | $28.16M derived: sum of 4 quarters · filed 2024-06-28 | ||||
| 2022-12-31 | $8.59M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | $16.86M derived: sum of 2 quarters · filed 2024-06-06 | $21.82M derived: sum of 3 quarters · filed 2024-06-06 | $25.83M 10-K · filed 2024-06-06 | $27.20M 10-K · filed 2023-03-31 | |||
| 2022-09-30 | $8.27M 10-Q/A · filed 2024-06-04 | $13.24M derived: sum of 2 quarters · filed 2024-06-04 | $17.24M 10-Q/A · filed 2024-06-04 | $19.87M derived: sum of 4 quarters · filed 2024-06-04 | ||||
| 2022-06-30 | $4.97M 10-Q · filed 2023-08-10 | $8.97M 10-Q · filed 2023-08-10 | $11.60M derived: sum of 3 quarters · filed 2023-08-10 | $14.32M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $4.00M 10-Q · filed 2023-05-11 | $6.63M derived: sum of 2 quarters · filed 2023-05-11 | $9.36M derived: sum of 3 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $5.35M derived: sum of 2 quarters · filed 2023-03-31 | $10.27M 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | $2.72M 10-Q · filed 2022-11-21 | $7.64M 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |